Kevin R. Fletemeyer

Kevin R. Fletemeyer currently serves as the Senior Vice President of Product Innovation and Strategy at Prime Therapeutics since January 2023. With extensive experience in healthcare and financial management, Fletemeyer has held various leadership roles at Magellan Health since April 2009, including Chief Strategy Officer, Chief Financial Officer, and Senior Vice President of Magellan Rx Management. Responsibilities have included the development and execution of pharmacy benefit management strategies that utilize data analytics to enhance drug management solutions. Previous positions include Financial Analysis Manager at Green Tree Servicing and Financial Analyst at JPMorgan Chase. Fletemeyer holds a Master of Business Administration from the W. P. Carey School of Business at Arizona State University and a Bachelor of Science in Finance and Business Process Management from Indiana University Bloomington.